Table 5.
Descriptive statistics of marker expression, NCI-8070.
Marker | Treatment Arm | N | Minimum | 1st Tertile | Median | 2nd Tertile | Maximum |
---|---|---|---|---|---|---|---|
PTEN | Cetuximab | 16 | 481.0 | 1568.4 | 2237.5 | 2857.4 | 5307.1 |
Cetuximab + Sorafenib | 21 | 441.7 | 851.8 | 1293.0 | 2091.5 | 6263.3 | |
Total | 37 | 441.7 | 1177.3 | 1568.4 | 2385.9 | 6263.3 | |
PI3 p110 | Cetuximab | 16 | 311.4 | 882.1 | 986.5 | 1206.1 | 3101.4 |
Cetuximab + Sorafenib | 21 | 370.6 | 790.2 | 853.6 | 1049.3 | 2777.1 | |
Total | 37 | 311.4 | 801.0 | 882.1 | 1142.8 | 3101.4 |